Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 USD | +5.39% | +6.44% | -83.07% |
04-23 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
04-01 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Climaco
CEO | Chief Executive Officer | 55 | 31/08/17 |
Director of Finance/CFO | 45 | 12/11/19 | |
Sandra Silberman
CTO | Chief Tech/Sci/R&D Officer | 69 | 30/11/17 |
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 31/12/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Picker
CTO | Chief Tech/Sci/R&D Officer | 78 | 31/12/17 |
John Climaco
CEO | Chief Executive Officer | 55 | 31/08/17 |
Faith Charles
CHM | Chairman | 62 | 02/01/23 |
Jeffry Keyes
BRD | Director/Board Member | 51 | 24/06/18 |
Bettina Cockroft
BRD | Director/Board Member | 57 | 07/05/23 |
Jerzy Gumulka
BRD | Director/Board Member | 75 | 07/11/17 |
Carl Evans
BRD | Director/Board Member | 77 | 08/07/18 |
Amy Mahery
BRD | Director/Board Member | - | 01-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,634,932 | 9,621,176 ( 90.47 %) | 0 | 90.47 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-83.07% | 2.29M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CNSP Stock
- Company CNS Pharmaceuticals, Inc.